Targeting Lp(a): therapeutic insights and novel developments10' education - Oct. 12, 2022 - Prof. Erik Stroes, MD, PhD - Amsterdam, The Netherlands
Video navigation menu
- What's currently available to lower Lp(a)? 01:39
- Novel strategies to lower Lp(a) 05:17
- Summary 09:07
This lecture by Prof. Erik Stroes was part of the EBAC-accredited symposium "Lp(a): from causality to therapy" held during the ESC congress 2022.
Prof. Erik Stroes, MD, PhD is professor of Vascular Medicine at Amsterdam University Medical Center in Amsterdam, The Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by unrestricted educational grants from NewAmsterdam Pharma, Novartis, Sanofi and Roche Diagnostics.